Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

CDT vs DBVT vs ALKS vs CSWC vs ARCC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CDT
CDT Equity Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$368K
5Y Perf.-100.0%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.+25.7%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+34.5%
CSWC
Capital Southwest Corporation

Asset Management

Financial ServicesNASDAQ • US
Market Cap$1.43B
5Y Perf.+1.1%
ARCC
Ares Capital Corporation

Asset Management

Financial ServicesNASDAQ • US
Market Cap$13.61B
5Y Perf.-9.5%

CDT vs DBVT vs ALKS vs CSWC vs ARCC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CDT logoCDT
DBVT logoDBVT
ALKS logoALKS
CSWC logoCSWC
ARCC logoARCC
IndustryBiotechnologyBiotechnologyBiotechnologyAsset ManagementAsset Management
Market Cap$368K$1712.35T$5.90B$1.43B$13.61B
Revenue (TTM)$696M$0.00$1.56B$164M$3.15B
Net Income (TTM)$17M$-168M$153M$103M$1.15B
Gross Margin36.9%65.4%66.5%75.7%
Operating Margin6.4%12.3%48.5%69.7%
Forward P/E0.0x24.8x10.1x9.9x
Total Debt$1.29B$22M$70M$956M$15.99B
Cash & Equiv.$390M$194M$1.12B$43M$924M

CDT vs DBVT vs ALKS vs CSWC vs ARCCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CDT
DBVT
ALKS
CSWC
ARCC
StockMar 22May 26Return
CDT Equity Inc. (CDT)1000.0-100.0%
DBV Technologies S.… (DBVT)100125.7+25.7%
Alkermes plc (ALKS)100134.5+34.5%
Capital Southwest C… (CSWC)100101.1+1.1%
Ares Capital Corpor… (ARCC)10090.5-9.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: CDT vs DBVT vs ALKS vs CSWC vs ARCC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CDT and CSWC are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. Capital Southwest Corporation is the stronger pick specifically for profitability and margin quality and dividend income and shareholder returns. DBVT, ALKS, and ARCC also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CDT
CDT Equity Inc.
The Growth Leader

CDT has the current edge in this matchup, primarily because of its strength in growth and value.

  • 8.9% revenue growth vs DBVT's -100.0%
  • Lower P/E (0.0x vs 10.1x)
Best for: growth and value
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT ranks third and is worth considering specifically for momentum.

  • +110.4% vs CDT's -99.8%
Best for: momentum
ALKS
Alkermes plc
The Defensive Pick

ALKS is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • 5.4% ROA vs DBVT's -89.0%
Best for: sleep-well-at-night
CSWC
Capital Southwest Corporation
The Banking Pick

CSWC is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.

  • Dividend streak 3 yrs, beta 0.84, yield 10.2%
  • 234.2% 10Y total return vs ALKS's -11.0%
  • Beta 0.84, yield 10.2%
  • NIM 7.0% vs ARCC's 3.6%
Best for: income & stability and long-term compounding
ARCC
Ares Capital Corporation
The Banking Pick

ARCC is the clearest fit if your priority is growth exposure.

  • Rev growth 32.9%, EPS growth -23.8%
  • Beta 0.77 vs CDT's 1.84
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCDT logoCDT8.9% revenue growth vs DBVT's -100.0%
ValueCDT logoCDTLower P/E (0.0x vs 10.1x)
Quality / MarginsCSWC logoCSWC43.1% margin vs DBVT's 0.3%
Stability / SafetyARCC logoARCCBeta 0.77 vs CDT's 1.84
DividendsCSWC logoCSWC10.2% yield, 3-year raise streak, vs ARCC's 2.0%, (3 stocks pay no dividend)
Momentum (1Y)DBVT logoDBVT+110.4% vs CDT's -99.8%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs DBVT's -89.0%

CDT vs DBVT vs ALKS vs CSWC vs ARCC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CDTCDT Equity Inc.
FY 2024
Automation Solutions
100.0%$1.3B
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
CSWCCapital Southwest Corporation

Segment breakdown not available.

ARCCAres Capital Corporation

Segment breakdown not available.

CDT vs DBVT vs ALKS vs CSWC vs ARCC — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCSWCLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

ARCC leads this category, winning 3 of 5 comparable metrics.

ARCC and DBVT operate at a comparable scale, with $3.1B and $0 in trailing revenue. CSWC is the more profitable business, keeping 43.1% of every revenue dollar as net income compared to CDT's 2.4%.

MetricCDT logoCDTCDT Equity Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCSWC logoCSWCCapital Southwest…ARCC logoARCCAres Capital Corp…
RevenueTrailing 12 months$696M$0$1.6B$164M$3.1B
EBITDAEarnings before interest/tax$47M-$112M$212M$142M$2.0B
Net IncomeAfter-tax profit$17M-$168M$153M$103M$1.1B
Free Cash FlowCash after capex-$6M-$151M$392M-$69M$1.1B
Gross MarginGross profit ÷ Revenue+36.9%+65.4%+66.5%+75.7%
Operating MarginEBIT ÷ Revenue+6.4%+12.3%+48.5%+69.7%
Net MarginNet income ÷ Revenue+2.4%+9.8%+43.1%+41.3%
FCF MarginFCF ÷ Revenue-0.9%+25.1%-132.6%+36.3%
Rev. Growth (YoY)Latest quarter vs prior year+28.2%
EPS Growth (YoY)Latest quarter vs prior year+100.4%+91.5%-4.1%+113.3%-63.9%
ARCC leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

CDT leads this category, winning 3 of 6 comparable metrics.

At 0.0x trailing earnings, CDT trades at a 100% valuation discount to ALKS's 24.8x P/E. On an enterprise value basis, CDT's 2.4x EV/EBITDA is more attractive than CSWC's 27.4x.

MetricCDT logoCDTCDT Equity Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCSWC logoCSWCCapital Southwest…ARCC logoARCCAres Capital Corp…
Market CapShares × price$367,825$1712.35T$5.9B$1.4B$13.6B
Enterprise ValueMkt cap + debt − cash$896M$1712.35T$4.9B$2.3B$28.7B
Trailing P/EPrice ÷ TTM EPS0.00x-0.76x24.76x16.32x10.19x
Forward P/EPrice ÷ next-FY EPS est.10.06x9.92x
PEG RatioP/E ÷ EPS growth rate0.99x
EV / EBITDAEnterprise value multiple2.43x17.25x27.43x13.09x
Price / SalesMarket cap ÷ Revenue0.00x4.00x8.71x4.33x
Price / BookPrice ÷ Book value/share0.00x0.66x3.28x1.39x0.93x
Price / FCFMarket cap ÷ FCF12.28x11.92x
CDT leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 5 of 9 comparable metrics.

CSWC delivers a 10.3% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARCC's 1.12x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs CSWC's 1/9, reflecting strong financial health.

MetricCDT logoCDTCDT Equity Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCSWC logoCSWCCapital Southwest…ARCC logoARCCAres Capital Corp…
ROE (TTM)Return on equity+2.6%-130.2%+8.8%+10.3%+8.1%
ROA (TTM)Return on assets+1.0%-89.0%+5.4%+4.8%+3.8%
ROICReturn on invested capital+21.9%+18.9%+3.5%+5.7%
ROCEReturn on capital employed+22.2%-145.7%+14.2%+4.6%+7.5%
Piotroski ScoreFundamental quality 0–964714
Debt / EquityFinancial leverage1.02x0.13x0.04x1.08x1.12x
Net DebtTotal debt minus cash$896M-$172M-$1.0B$913M$15.1B
Cash & Equiv.Liquid assets$390M$194M$1.1B$43M$924M
Total DebtShort + long-term debt$1.3B$22M$70M$956M$16.0B
Interest CoverageEBIT ÷ Interest expense-1.05x-189.82x32.30x2.91x2.98x
ALKS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CSWC leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $0 for CDT. Over the past 12 months, DBVT leads with a +110.4% total return vs CDT's -99.8%. The 3-year compound annual growth rate (CAGR) favors CSWC at 20.7% vs CDT's -97.4% — a key indicator of consistent wealth creation.

MetricCDT logoCDTCDT Equity Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCSWC logoCSWCCapital Southwest…ARCC logoARCCAres Capital Corp…
YTD ReturnYear-to-date-94.2%+4.9%+25.3%+11.4%-4.9%
1-Year ReturnPast 12 months-99.8%+110.4%+16.5%+34.0%+0.4%
3-Year ReturnCumulative with dividends-100.0%+19.7%+14.5%+75.8%+34.2%
5-Year ReturnCumulative with dividends-100.0%-69.1%+60.9%+51.4%+47.0%
10-Year ReturnCumulative with dividends-100.0%-87.0%-11.0%+234.2%+139.2%
CAGR (3Y)Annualised 3-year return-97.4%+6.2%+4.6%+20.7%+10.3%
CSWC leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CSWC and ARCC each lead in 1 of 2 comparable metrics.

ARCC is the less volatile stock with a 0.77 beta — it tends to amplify market swings less than CDT's 1.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSWC currently trades 98.2% from its 52-week high vs CDT's 0.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCDT logoCDTCDT Equity Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCSWC logoCSWCCapital Southwest…ARCC logoARCCAres Capital Corp…
Beta (5Y)Sensitivity to S&P 5001.84x1.26x1.06x0.84x0.77x
52-Week HighHighest price in past year$1425.00$26.18$36.60$24.43$23.42
52-Week LowLowest price in past year$1.20$7.53$25.17$19.37$17.40
% of 52W HighCurrent price vs 52-week peak+0.1%+76.3%+96.7%+98.2%+81.0%
RSI (14)Momentum oscillator 0–10027.248.160.263.756.7
Avg Volume (50D)Average daily shares traded126K252K2.3M664K7.5M
Evenly matched — CSWC and ARCC each lead in 1 of 2 comparable metrics.

Analyst Outlook

CSWC leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: DBVT as "Buy", ALKS as "Buy", CSWC as "Buy", ARCC as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs -6.2% for CSWC (target: $23). For income investors, CSWC offers the higher dividend yield at 10.20% vs ARCC's 2.02%.

MetricCDT logoCDTCDT Equity Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcCSWC logoCSWCCapital Southwest…ARCC logoARCCAres Capital Corp…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$46.33$44.00$22.50$21.88
# AnalystsCovering analysts15281032
Dividend YieldAnnual dividend ÷ price+10.2%+2.0%
Dividend StreakConsecutive years of raises10030
Dividend / ShareAnnual DPS$2.45$0.38
Buyback YieldShare repurchases ÷ mkt cap+28.8%0.0%+0.5%0.0%0.0%
CSWC leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

CSWC leads in 2 of 6 categories (Total Returns, Analyst Outlook). ARCC leads in 1 (Income & Cash Flow). 1 tied.

Best OverallCapital Southwest Corporati… (CSWC)Leads 2 of 6 categories
Loading custom metrics...

CDT vs DBVT vs ALKS vs CSWC vs ARCC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CDT or DBVT or ALKS or CSWC or ARCC a better buy right now?

For growth investors, Ares Capital Corporation (ARCC) is the stronger pick with 32.

9% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). CDT Equity Inc. (CDT) offers the better valuation at 0. 0x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CDT or DBVT or ALKS or CSWC or ARCC?

On trailing P/E, CDT Equity Inc.

(CDT) is the cheapest at 0. 0x versus Alkermes plc at 24. 8x. On forward P/E, Ares Capital Corporation is actually cheaper at 9. 9x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — CDT or DBVT or ALKS or CSWC or ARCC?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -100. 0% for CDT Equity Inc. (CDT). Over 10 years, the gap is even starker: CSWC returned +234. 2% versus CDT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CDT or DBVT or ALKS or CSWC or ARCC?

By beta (market sensitivity over 5 years), Ares Capital Corporation (ARCC) is the lower-risk stock at 0.

77β versus CDT Equity Inc. 's 1. 84β — meaning CDT is approximately 139% more volatile than ARCC relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 112% for Ares Capital Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — CDT or DBVT or ALKS or CSWC or ARCC?

By revenue growth (latest reported year), Ares Capital Corporation (ARCC) is pulling ahead at 32.

9% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: CDT Equity Inc. grew EPS 128. 8% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CDT or DBVT or ALKS or CSWC or ARCC?

Capital Southwest Corporation (CSWC) is the more profitable company, earning 43.

1% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 43. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ARCC leads at 69. 7% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CDT or DBVT or ALKS or CSWC or ARCC more undervalued right now?

On forward earnings alone, Ares Capital Corporation (ARCC) trades at 9.

9x forward P/E versus 10. 1x for Capital Southwest Corporation — 0. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DBVT: 131. 8% to $46. 33.

08

Which pays a better dividend — CDT or DBVT or ALKS or CSWC or ARCC?

In this comparison, CSWC (10.

2% yield), ARCC (2. 0% yield) pay a dividend. CDT, DBVT, ALKS do not pay a meaningful dividend and should not be held primarily for income.

09

Is CDT or DBVT or ALKS or CSWC or ARCC better for a retirement portfolio?

For long-horizon retirement investors, Capital Southwest Corporation (CSWC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

84), 10. 2% yield, +234. 2% 10Y return). CDT Equity Inc. (CDT) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CSWC: +234. 2%, CDT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CDT and DBVT and ALKS and CSWC and ARCC?

These companies operate in different sectors (CDT (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and CSWC (Financial Services) and ARCC (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CDT is a small-cap deep-value stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; CSWC is a small-cap deep-value stock; ARCC is a mid-cap high-growth stock. CSWC, ARCC pay a dividend while CDT, DBVT, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CDT

Quality Business

  • Sector: Healthcare
  • Market Cap > $20B
  • Gross Margin > 22%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

CSWC

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 25%
Run This Screen
Stocks Like

ARCC

High-Growth Quality Leader

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 16%
  • Net Margin > 24%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.